Carmen Priolo

2.5k total citations
35 papers, 1.4k citations indexed

About

Carmen Priolo is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Carmen Priolo has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Physiology and 13 papers in Cancer Research. Recurrent topics in Carmen Priolo's work include Tuberous Sclerosis Complex Research (12 papers), Cancer, Lipids, and Metabolism (10 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Carmen Priolo is often cited by papers focused on Tuberous Sclerosis Complex Research (12 papers), Cancer, Lipids, and Metabolism (10 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Carmen Priolo collaborates with scholars based in United States, Italy and United Kingdom. Carmen Priolo's co-authors include Massimo Loda, Giorgia Zadra, Elizabeth P. Henske, Stephen P. Finn, Ewa Sicińska, Alfredo Pontecorvi, Natalia Scaglia, Cornelia Photopoulos, Alessandro Porrello and Antonella Farsetti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Carmen Priolo

34 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Priolo United States 20 930 498 317 312 161 35 1.4k
Hiromi I. Wettersten United States 18 907 1.0× 569 1.1× 399 1.3× 235 0.8× 93 0.6× 29 1.5k
Francesca Maddalena Italy 25 1.3k 1.4× 406 0.8× 180 0.6× 397 1.3× 78 0.5× 50 1.8k
Takako Asano Japan 27 1.3k 1.4× 469 0.9× 412 1.3× 378 1.2× 97 0.6× 84 2.1k
Giorgia Zadra United States 21 1.1k 1.2× 925 1.9× 480 1.5× 366 1.2× 74 0.5× 39 1.9k
Bo Qiu China 19 1.2k 1.3× 1.0k 2.0× 292 0.9× 252 0.8× 107 0.7× 33 2.0k
Myriem Boufraqech United States 23 1.1k 1.1× 540 1.1× 153 0.5× 366 1.2× 123 0.8× 45 1.8k
Elin Thysell Sweden 18 568 0.6× 359 0.7× 415 1.3× 197 0.6× 67 0.4× 38 1.1k
Melissa Dumble United States 17 749 0.8× 244 0.5× 145 0.5× 411 1.3× 101 0.6× 28 1.3k
Xuesong Ouyang United States 18 1.3k 1.4× 333 0.7× 508 1.6× 419 1.3× 76 0.5× 28 1.8k
Hong Yan China 21 593 0.6× 340 0.7× 243 0.8× 317 1.0× 46 0.3× 70 1.2k

Countries citing papers authored by Carmen Priolo

Since Specialization
Citations

This map shows the geographic impact of Carmen Priolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Priolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Priolo more than expected).

Fields of papers citing papers by Carmen Priolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Priolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Priolo. The network helps show where Carmen Priolo may publish in the future.

Co-authorship network of co-authors of Carmen Priolo

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Priolo. A scholar is included among the top collaborators of Carmen Priolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Priolo. Carmen Priolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khabibullin, Damir, Tiegang Han, Yan Tang, et al.. (2025). Targeting KIT With Antibody-Drug Conjugates in Chromophobe Renal Cell Carcinoma. Clinical Genitourinary Cancer. 23(4). 102359–102359. 1 indexed citations
2.
Salem, S., Tiegang Han, Damir Khabibullin, et al.. (2025). Targeting FSP1 to induce ferroptosis in chromophobe renal cell carcinoma. Oncogene. 44(42). 4075–4086. 3 indexed citations
3.
Qin, Xingping, Damir Khabibullin, Tiegang Han, et al.. (2025). BCL-xL dependency in chromophobe renal cell carcinoma. Cancer Gene Therapy. 32(10). 1133–1143.
4.
Shrestha, Shikshya, Elio Adib, Dean J. Aguiar, et al.. (2022). Angiotensin II receptor type 1 blockade regulates Klotho expression to induce TSC2-deficient cell death. Journal of Biological Chemistry. 298(11). 102580–102580. 1 indexed citations
5.
Xiao, Wusheng, William M. Oldham, Carmen Priolo, Arvind K. Pandey, & Joseph Loscalzo. (2021). Immunometabolic Endothelial Phenotypes: Integrating Inflammation and Glucose Metabolism. Circulation Research. 129(1). 9–29. 63 indexed citations
6.
Kirkpatrick, Jesse D., Ava P. Soleimany, Jaideep S. Dudani, et al.. (2021). Protease activity sensors enable real-time treatment response monitoring in lymphangioleiomyomatosis. European Respiratory Journal. 59(4). 2100664–2100664. 4 indexed citations
7.
Sadow, Peter M., et al.. (2020). Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis. Cancer Research. 80(13). 2751–2763. 7 indexed citations
8.
Priolo, Carmen, Zsuzsanna K. Zsengellér, Alfredo Pontecorvi, et al.. (2020). Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in BRAF V600E Papillary Thyroid Carcinoma. Thyroid. 31(9). 1335–1358. 21 indexed citations
9.
Shrestha, Shikshya, Woohyun Cho, Mark A. Perrella, et al.. (2019). Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways. PLoS ONE. 14(4). e0213831–e0213831. 9 indexed citations
10.
Cui, Ye, Wendy K. Steagall, Gustavo Pacheco–Rodriguez, et al.. (2017). Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation. Cancer Research. 77(6). 1492–1502. 15 indexed citations
11.
Priolo, Carmen, Stéphane J. H. Ricoult, Damir Khabibullin, et al.. (2015). Tuberous Sclerosis Complex 2 Loss Increases Lysophosphatidylcholine Synthesis in Lymphangioleiomyomatosis. American Journal of Respiratory Cell and Molecular Biology. 53(1). 33–41. 24 indexed citations
12.
Medvetz, Doug, Yang Sun, Chenggang Li, et al.. (2014). High-Throughput Drug Screen Identifies Chelerythrine as a Selective Inducer of Death in a TSC2-null Setting. Molecular Cancer Research. 13(1). 50–62. 21 indexed citations
13.
Priolo, Carmen, Saumyadipta Pyne, J.A. Rose, et al.. (2014). AKT1 and MYC Induce Distinctive Metabolic Fingerprints in Human Prostate Cancer. Cancer Research. 74(24). 7198–7204. 112 indexed citations
14.
Courtney, Kevin D., Judith Manola, Aymen Elfiky, et al.. (2014). A Phase I Study of Everolimus and Docetaxel in Patients With Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer. 13(2). 113–123. 30 indexed citations
15.
Parkhitko, Andrey A., Carmen Priolo, Jonathan L. Coloff, et al.. (2013). Autophagy-Dependent Metabolic Reprogramming Sensitizes TSC2-Deficient Cells to the Antimetabolite 6-Aminonicotinamide. Molecular Cancer Research. 12(1). 48–57. 50 indexed citations
16.
Trindade, Anil J., et al.. (2013). MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM). PLoS ONE. 8(3). e60014–e60014. 30 indexed citations
17.
Nucera, Carmelo, Alessandro Porrello, Zeus A. Antonello, et al.. (2010). B-Raf V600E and thrombospondin-1 promote thyroid cancer progression. Proceedings of the National Academy of Sciences. 107(23). 10649–10654. 149 indexed citations
18.
Priolo, Carmen, Michelle Agostini, Natalie Vena, et al.. (2010). Establishment and Genomic Characterization of Mouse Xenografts of Human Primary Prostate Tumors. American Journal Of Pathology. 176(4). 1901–1913. 44 indexed citations
19.
Nucera, Carmelo, Jérôme Eeckhoute, Stephen P. Finn, et al.. (2009). FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma. Clinical Cancer Research. 15(11). 3680–3689. 67 indexed citations
20.
Priolo, Carmen, Dan Tang, Barbara Benassi, et al.. (2006). The Isopeptidase USP2a Protects Human Prostate Cancer from Apoptosis. Cancer Research. 66(17). 8625–8632. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiromi I. Wettersten Breakdown of academic impact, for papers by Francesca Maddalena Breakdown of academic impact, for papers by Takako Asano Breakdown of academic impact, for papers by Giorgia Zadra Breakdown of academic impact, for papers by Bo Qiu Breakdown of academic impact, for papers by Myriem Boufraqech Breakdown of academic impact, for papers by Elin Thysell Breakdown of academic impact, for papers by Melissa Dumble Breakdown of academic impact, for papers by Xuesong Ouyang Breakdown of academic impact, for papers by Hong Yan
Rankless by CCL
2026